These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 20146995)
21. Guidelines ease up on glycemic control for some patients with type 2 diabetes. Mitka M JAMA; 2012 Jun; 307(21):2243-4. PubMed ID: 22706812 [No Abstract] [Full Text] [Related]
22. Unrecognized hypo- and hyperglycemia in well-controlled patients with type 2 diabetes mellitus: the results of continuous glucose monitoring. Hay LC; Wilmshurst EG; Fulcher G Diabetes Technol Ther; 2003; 5(1):19-26. PubMed ID: 12725703 [TBL] [Abstract][Full Text] [Related]
23. Moving beyond HbA1c and plasma glucose levels to understand glycemic status in type 2 diabetes mellitus. Vijayakumar V; Mavathur R; Aruchunan M; Nandi Krishnamurthy M J Diabetes; 2018 Jul; 10(7):609-610. PubMed ID: 29437298 [No Abstract] [Full Text] [Related]
24. Current antihyperglycemic treatment guidelines and algorithms for patients with type 2 diabetes mellitus. Blonde L Am J Med; 2010 Mar; 123(3 Suppl):S12-8. PubMed ID: 20206727 [TBL] [Abstract][Full Text] [Related]
25. Intensive Glycemic Control in Type 2 Diabetes Mellitus -- A Balancing Act of Latent Benefit and Avoidable Harm: A Teachable Moment. Rodriguez-Gutierrez R; Lipska KJ; McCoy RG JAMA Intern Med; 2016 Mar; 176(3):300-1. PubMed ID: 26882223 [No Abstract] [Full Text] [Related]
26. Glycemic control and safety in Chinese patients with type 2 diabetes mellitus who switched from premixed insulin to insulin glargine plus oral antidiabetics: a large, prospective, observational study. Zhang B; Zhao J; Yang W; Diabetes Metab Res Rev; 2017 Mar; 33(3):. PubMed ID: 27667797 [TBL] [Abstract][Full Text] [Related]
27. The co-formulation of insulin degludec and insulin aspart lowers fasting plasma glucose and rates of confirmed and nocturnal hypoglycaemia, independent of baseline glycated haemoglobin levels, disease duration or body mass index: A pooled meta-analysis of phase III studies in patients with type 2 diabetes. Haluzík M; Fulcher G; Pieber TR; Bardtrum L; Tutkunkardas D; Rodbard HW Diabetes Obes Metab; 2018 Jul; 20(7):1585-1592. PubMed ID: 29451706 [TBL] [Abstract][Full Text] [Related]
28. Association of diabetes treatment with long-term glycemic patterns in patients with type 2 diabetes mellitus: A prospective cohort study. Luo M; Tan CS; Lim WY; Chia KS; Tang WE; Tai ES; Venkataraman K Diabetes Metab Res Rev; 2019 May; 35(4):e3122. PubMed ID: 30600922 [TBL] [Abstract][Full Text] [Related]
29. Glycemic control and use of glucose-lowering medications in hospital-admitted type 2 diabetes patients over 80 years. Gotfredsen DR; Vinther S; Petersen TS; Cortes R; Jensen TB; Jimenez-Solem E; Christensen MB Sci Rep; 2020 Mar; 10(1):4095. PubMed ID: 32139733 [TBL] [Abstract][Full Text] [Related]
31. Development of a New Tool to Assess Bolus Calculation and Carbohydrate Estimation. Ehrmann D; Hermanns N; Reimer A; Weißmann J; Haak T; Kulzer B Diabetes Technol Ther; 2016 Mar; 18(3):194-9. PubMed ID: 26907638 [TBL] [Abstract][Full Text] [Related]
32. Relationship among A1C, hypoglycemia, and hyperglycemia in Japanese with type 2 diabetes--results from continuous glucose monitoring data. Morimoto A; Nishimura R; Tsujino D; Taki K; Tajima N; Utsunomiya K Diabetes Technol Ther; 2011 Jun; 13(6):667-70. PubMed ID: 21457068 [TBL] [Abstract][Full Text] [Related]
33. Trends in medication utilization, glycemic control and outcomes among type 2 diabetes patients in a tertiary referral center in Singapore from 2007 to 2017. Tan YZ; Cheen MHH; Goh SY; Bee YM; Lim PS; Khee GY; Thumboo J J Diabetes; 2019 Jul; 11(7):573-581. PubMed ID: 30556375 [TBL] [Abstract][Full Text] [Related]
35. [Correlation of glycosylated serum protein and glycosylated hemoglobin in patients with diabetes mellitus type 2 at various stages of metabolic compensation]. Plechanow J; Bartosiewicz W; Szczepanik Z Pol Arch Med Wewn; 1987 Sep; 78(3):149-53. PubMed ID: 3271294 [No Abstract] [Full Text] [Related]
36. The importance of postprandial glucose to treatments and outcomes in patients with type 2 diabetes. Herman ME; Moore RS Manag Care Interface; 2001 Nov; 14(11):63-9. PubMed ID: 11715766 [TBL] [Abstract][Full Text] [Related]
37. Monitoring glycemia in diabetes. Healy SJ; Dungan KM Med Clin North Am; 2015 Jan; 99(1):35-45. PubMed ID: 25456642 [TBL] [Abstract][Full Text] [Related]
38. A taxi driver with type 2 diabetes. Brice R BMJ; 2009 Apr; 338():b1369. PubMed ID: 19403570 [No Abstract] [Full Text] [Related]
39. Effect of once-weekly dulaglutide on glycated haemoglobin (HbA1c) and fasting blood glucose in patient subpopulations by gender, duration of diabetes and baseline HbA1c. Gallwitz B; Dagogo-Jack S; Thieu V; Garcia-Perez LE; Pavo I; Yu M; Robertson KE; Zhang N; Giorgino F Diabetes Obes Metab; 2018 Feb; 20(2):409-418. PubMed ID: 28817231 [TBL] [Abstract][Full Text] [Related]
40. Insulin requirement profiles in Japanese hospitalized subjects with type 2 diabetes treated with basal-bolus insulin therapy. Shimoda S; Okubo M; Koga K; Sekigami T; Kawashima J; Kukidome D; Igata M; Ishii N; Shimakawa A; Matsumura T; Motoshima H; Furukawa N; Nishida K; Araki E Endocr J; 2015; 62(2):209-16. PubMed ID: 25392020 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]